Acrivon Therapeutics (ACRV) Stock Price & Financial Analysis
Acrivon Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Acrivon Therapeutics
What is the current stock price for ACRV?
As of the latest trading session, ACRV stock trades at $1.57. The 52-week range is $1.15–$3.56, with a day range of $1.51–$1.61.
What is the P/E ratio for ACRV?
The P/E ratio (Price-to-Earnings) for ACRV is shown in the Key Statistics section. This valuation metric helps compare Acrivon Therapeutics, Inc. to industry peers.
Does ACRV pay dividends?
Acrivon Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ACRV?
Based on 5 analysts, the consensus for ACRV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ACRV?
Acrivon Therapeutics's market capitalization is $60.8M, classifying it as a micro-cap company. Acrivon Therapeutics operates in the Healthcare sector within the Biotechnology industry.